ID   S29A2_RAT               Reviewed;         456 AA.
AC   O54699;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   24-JUL-2024, entry version 147.
DE   RecName: Full=Equilibrative nucleoside transporter 2 {ECO:0000303|PubMed:9353301};
DE            Short=rENT2 {ECO:0000303|PubMed:9353301};
DE   AltName: Full=Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter {ECO:0000303|PubMed:9353301};
DE            Short=Equilibrative NBMPR-insensitive nucleoside transporter {ECO:0000303|PubMed:9353301};
DE   AltName: Full=Nucleoside transporter, ei-type {ECO:0000303|PubMed:9353301};
DE   AltName: Full=Solute carrier family 29 member 2 {ECO:0000250|UniProtKB:Q14542};
GN   Name=Slc29a2 {ECO:0000312|RGD:69296}; Synonyms=Ent2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, AND
RP   MISCELLANEOUS.
RC   STRAIN=Sprague-Dawley; TISSUE=Jejunum;
RX   PubMed=9353301; DOI=10.1074/jbc.272.45.28423;
RA   Yao S.Y.M., Ng A.M.L., Muzyka W.R., Griffiths M., Cass C.E., Baldwin S.A.,
RA   Young J.D.;
RT   "Molecular cloning and functional characterization of
RT   nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei)
RT   equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat
RT   tissues.";
RL   J. Biol. Chem. 272:28423-28430(1997).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=23639800; DOI=10.1124/jpet.113.203265;
RA   Klein D.M., Evans K.K., Hardwick R.N., Dantzler W.H., Wright S.H.,
RA   Cherrington N.J.;
RT   "Basolateral uptake of nucleosides by Sertoli cells is mediated primarily
RT   by equilibrative nucleoside transporter 1.";
RL   J. Pharmacol. Exp. Ther. 346:121-129(2013).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE
RP   SPECIFICITY, AND MISCELLANEOUS.
RX   PubMed=18048066; DOI=10.1016/j.mvr.2007.10.002;
RA   Robillard K.R., Bone D.B., Hammond J.R.;
RT   "Hypoxanthine uptake and release by equilibrative nucleoside transporter 2
RT   (ENT2) of rat microvascular endothelial cells.";
RL   Microvasc. Res. 75:351-357(2008).
CC   -!- FUNCTION: Bidirectional uniporter involved in the facilitative
CC       transport of nucleosides and nucleobases, and contributes to
CC       maintaining their cellular homeostasis (PubMed:18048066,
CC       PubMed:9353301). Functions as a Na(+)-independent, passive transporter
CC       (By similarity). Involved in the transport of nucleosides such as
CC       inosine, adenosine, uridine, thymidine, cytidine and guanosine
CC       (PubMed:9353301). Also able to transport purine nucleobases
CC       (hypoxanthine, adenine, guanine) and pyrimidine nucleobases (thymine,
CC       uracil) (PubMed:18048066). Involved in nucleoside transport at
CC       basolateral membrane of kidney cells, allowing liver absorption of
CC       nucleoside metabolites (By similarity). Mediates apical nucleoside
CC       uptake into Sertoli cells, thereby regulating the transport of
CC       nucleosides in testis across the blood-testis-barrier
CC       (PubMed:23639800). Mediates both the influx and efflux of hypoxanthine
CC       in skeletal muscle microvascular endothelial cells to control the
CC       amount of intracellular hypoxanthine available for xanthine oxidase-
CC       mediated ROS production (PubMed:18048066).
CC       {ECO:0000250|UniProtKB:Q14542, ECO:0000269|PubMed:18048066,
CC       ECO:0000269|PubMed:23639800, ECO:0000269|PubMed:9353301}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uridine(out) = uridine(in); Xref=Rhea:RHEA:71519,
CC         ChEBI:CHEBI:16704; Evidence={ECO:0000269|PubMed:9353301};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71520;
CC         Evidence={ECO:0000305|PubMed:9353301};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71521;
CC         Evidence={ECO:0000305|PubMed:9353301};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=inosine(in) = inosine(out); Xref=Rhea:RHEA:75375,
CC         ChEBI:CHEBI:17596; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75376;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:75377;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine(in) = adenosine(out); Xref=Rhea:RHEA:75343,
CC         ChEBI:CHEBI:16335; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75344;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:75345;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=thymidine(in) = thymidine(out); Xref=Rhea:RHEA:75363,
CC         ChEBI:CHEBI:17748; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75364;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:75365;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hypoxanthine(out) = hypoxanthine(in); Xref=Rhea:RHEA:71515,
CC         ChEBI:CHEBI:17368; Evidence={ECO:0000269|PubMed:18048066};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71516;
CC         Evidence={ECO:0000269|PubMed:18048066};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71517;
CC         Evidence={ECO:0000269|PubMed:18048066};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenine(out) = adenine(in); Xref=Rhea:RHEA:71523,
CC         ChEBI:CHEBI:16708; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71524;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71525;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cytidine(in) = cytidine(out); Xref=Rhea:RHEA:75367,
CC         ChEBI:CHEBI:17562; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75368;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:75369;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=thymine(out) = thymine(in); Xref=Rhea:RHEA:71527,
CC         ChEBI:CHEBI:17821; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71528;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71529;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=uracil(in) = uracil(out); Xref=Rhea:RHEA:69404,
CC         ChEBI:CHEBI:17568; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69405;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:69406;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanine(out) = guanine(in); Xref=Rhea:RHEA:71531,
CC         ChEBI:CHEBI:16235; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71532;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:71533;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanosine(in) = guanosine(out); Xref=Rhea:RHEA:75371,
CC         ChEBI:CHEBI:16750; Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75372;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:75373;
CC         Evidence={ECO:0000250|UniProtKB:Q14542};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for hypoxanthine (for influx kinetics)
CC         {ECO:0000269|PubMed:18048066};
CC         KM=189 uM for hypoxanthine (for efflux kinetics)
CC         {ECO:0000269|PubMed:18048066};
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:23639800}; Multi-pass membrane protein
CC       {ECO:0000305}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:Q14542}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Localized to the apical membrane of Sertoli cells.
CC       {ECO:0000269|PubMed:23639800}.
CC   -!- TISSUE SPECIFICITY: Expressed in squeletal muscles (PubMed:18048066).
CC       Expressed in testis at the blood-brain-barrier (PubMed:23639800).
CC       {ECO:0000269|PubMed:18048066, ECO:0000269|PubMed:23639800}.
CC   -!- MISCELLANEOUS: Transport activity is insensitive to nanomolar
CC       concentrations of the inhibitor nitrobenzylmercaptopurine riboside
CC       (NBMPR) (PubMed:18048066, PubMed:9353301). Inhibited by higher
CC       concentrations of NBMPR (1uM-10uM) (PubMed:18048066, PubMed:9353301).
CC       {ECO:0000269|PubMed:18048066, ECO:0000269|PubMed:9353301}.
CC   -!- SIMILARITY: Belongs to the SLC29A/ENT transporter (TC 2.A.57) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF015305; AAB88050.1; -; mRNA.
DR   RefSeq; NP_113926.1; NM_031738.1.
DR   RefSeq; XP_017445770.1; XM_017590281.1.
DR   RefSeq; XP_017459751.1; XM_017604262.1.
DR   AlphaFoldDB; O54699; -.
DR   SMR; O54699; -.
DR   STRING; 10116.ENSRNOP00000027178; -.
DR   BindingDB; O54699; -.
DR   ChEMBL; CHEMBL1287614; -.
DR   DrugCentral; O54699; -.
DR   TCDB; 2.A.57.1.4; the equilibrative nucleoside transporter (ent) family.
DR   GlyCosmos; O54699; 2 sites, No reported glycans.
DR   GlyGen; O54699; 2 sites.
DR   PhosphoSitePlus; O54699; -.
DR   PaxDb; 10116-ENSRNOP00000027178; -.
DR   GeneID; 65194; -.
DR   KEGG; rno:65194; -.
DR   UCSC; RGD:69296; rat.
DR   AGR; RGD:69296; -.
DR   CTD; 3177; -.
DR   RGD; 69296; Slc29a2.
DR   VEuPathDB; HostDB:ENSRNOG00000020025; -.
DR   eggNOG; KOG1479; Eukaryota.
DR   HOGENOM; CLU_021611_6_0_1; -.
DR   InParanoid; O54699; -.
DR   OrthoDB; 517168at2759; -.
DR   PhylomeDB; O54699; -.
DR   TreeFam; TF313950; -.
DR   Reactome; R-RNO-83936; Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane.
DR   Reactome; R-RNO-9748787; Azathioprine ADME.
DR   PRO; PR:O54699; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020025; Expressed in skeletal muscle tissue and 16 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0015207; F:adenine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015212; F:cytidine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015208; F:guanine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005326; F:neurotransmitter transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015205; F:nucleobase transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005337; F:nucleoside transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015211; F:purine nucleoside transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015210; F:uracil transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015213; F:uridine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015853; P:adenine transport; IDA:RGD.
DR   GO; GO:0032238; P:adenosine transport; IDA:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0015861; P:cytidine transport; ISS:UniProtKB.
DR   GO; GO:1903716; P:guanine transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0015854; P:guanine transport; IMP:RGD.
DR   GO; GO:0035344; P:hypoxanthine transport; IDA:UniProtKB.
DR   GO; GO:0035340; P:inosine transport; ISS:UniProtKB.
DR   GO; GO:0007595; P:lactation; IEP:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; ISO:RGD.
DR   GO; GO:0001504; P:neurotransmitter uptake; ISO:RGD.
DR   GO; GO:0015851; P:nucleobase transport; IDA:UniProtKB.
DR   GO; GO:1901642; P:nucleoside transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0015858; P:nucleoside transport; IDA:UniProtKB.
DR   GO; GO:1904823; P:purine nucleobase transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0015860; P:purine nucleoside transmembrane transport; ISO:RGD.
DR   GO; GO:0072531; P:pyrimidine-containing compound transmembrane transport; ISO:RGD.
DR   GO; GO:0035364; P:thymine transport; IDA:RGD.
DR   GO; GO:1903791; P:uracil transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0015862; P:uridine transmembrane transport; IDA:UniProtKB.
DR   InterPro; IPR034764; ENT1/ENT2.
DR   InterPro; IPR002259; Eqnu_transpt.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   NCBIfam; TIGR00939; 2a57; 1.
DR   PANTHER; PTHR10332; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; 1.
DR   PANTHER; PTHR10332:SF8; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; 1.
DR   Pfam; PF01733; Nucleoside_tran; 1.
DR   PIRSF; PIRSF016379; ENT; 1.
DR   PRINTS; PR01130; DERENTRNSPRT.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..456
FT                   /note="Equilibrative nucleoside transporter 2"
FT                   /id="PRO_0000209342"
FT   TOPO_DOM        1..12
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        13..29
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..68
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        69..93
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        94..97
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        98..116
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        117..124
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        125..143
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        144..160
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        161..185
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        186..192
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        193..213
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        214..291
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        292..311
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        312..323
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        324..342
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        343..359
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        360..378
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        379..393
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        394..413
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        414..431
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        432..452
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        453..456
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         251
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14542"
FT   CARBOHYD        47
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   456 AA;  50265 MW;  DA97C2C578E1EE9D CRC64;
     MAHGNAPRDS YHLVGISFFI LGLGTLLPWN FFITAIPYFQ GRLAGTNSSA ETPSTNHTSP
     TDTFNFNNWV TLLSQLPLLL FTLLNSFLYQ CIPESVRILG SLLAILLLFA LTAALVKVDL
     SPGLFFSITM ASVWFINSFC AVLQGSLFGQ LGTMPSTYST LFLSGQGLAG IFAALAMLTS
     LASGVDPQTS ALGYFITPCV GILLSIICYL SLPHLKFARY YLTKKPQAPV QELETKAELL
     GADEKNGIPV SPQQAGPTLD LDPEKELELG LEEPQKPGKP SVFVVFRKIW LTALCLVLVF
     TVTLSVFPAI TAMVTTSSNS PGKWSQFFNP ICCFLLFNVM DWLGRSLTSY FLWPDEDSQL
     LPLLVCLRFL FVPLFMLCHV PQRARLPIIF WQDAYFITFM LLFAISNGYF VSLTMCLAPR
     QVLPHEREVA GALMTFFLAL GLSCGASLSF LFKALL
//
